Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin

Ähnliche Einträge

• Risk factors for pulmonary embolism in patients with paralysis and deep venous thrombosis
  von: Keller, Karsten, et al.
  Veröffentlicht: (2021)
• Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin
  von: Harenberg, Job, et al.
  Veröffentlicht: (2003)
• Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis
  von: Riess, Hanno, et al.
  Veröffentlicht: (2003)
• Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin
  von: Harenberg, Job, et al.
  Veröffentlicht: (2001)
• Varicose veins are a risk factor for deep venous thrombosis in general practice patients
  von: Müller-Bühl, Uwe, et al.
  Veröffentlicht: (2012)